全文获取类型
收费全文 | 2158篇 |
免费 | 148篇 |
出版年
2022年 | 10篇 |
2021年 | 14篇 |
2020年 | 9篇 |
2019年 | 25篇 |
2018年 | 27篇 |
2017年 | 21篇 |
2016年 | 37篇 |
2015年 | 47篇 |
2014年 | 65篇 |
2013年 | 113篇 |
2012年 | 99篇 |
2011年 | 87篇 |
2010年 | 62篇 |
2009年 | 55篇 |
2008年 | 96篇 |
2007年 | 115篇 |
2006年 | 87篇 |
2005年 | 97篇 |
2004年 | 85篇 |
2003年 | 101篇 |
2002年 | 108篇 |
2001年 | 99篇 |
2000年 | 99篇 |
1999年 | 85篇 |
1998年 | 40篇 |
1997年 | 24篇 |
1996年 | 24篇 |
1995年 | 16篇 |
1994年 | 25篇 |
1993年 | 22篇 |
1992年 | 73篇 |
1991年 | 27篇 |
1990年 | 44篇 |
1989年 | 34篇 |
1988年 | 52篇 |
1987年 | 26篇 |
1986年 | 27篇 |
1985年 | 18篇 |
1984年 | 11篇 |
1983年 | 20篇 |
1982年 | 20篇 |
1981年 | 17篇 |
1980年 | 12篇 |
1979年 | 17篇 |
1978年 | 10篇 |
1977年 | 11篇 |
1975年 | 11篇 |
1974年 | 12篇 |
1973年 | 18篇 |
1971年 | 8篇 |
排序方式: 共有2306条查询结果,搜索用时 15 毫秒
131.
Hideo Ohkawa Reiko Shibaike Toshiko Hatanaka Junshi Miyamoto 《Bioscience, biotechnology, and biochemistry》2013,77(8):1605-1615
S-1358 was rapidly absorbed, metabolized and readily excreted via urine and feces from orally dosed rats. Excretion of radioactivity was almost complete within 4 days. The radioactivity was distributed mainly in stomach, intestines, liver and kidneys. It seems that S-1358 and its metabolites do not persist in organs and tissues following a single oral dosing.Major urinary metabolites of the benzyl-labeled S-1358 were p-(1,1-dimethyl-2-hydroxyethyl)benzyl methyl sulfide [B], p-(1,1-dimethyl-2-hydroxyethyl)benzyl methyl sulfone [A], p-(1-methyl-1-carboxylethyl)benzyl methyl sulfide [D], p-(1-methyl-1-carboxylethyl)benzyl methyl sulfone [C] and their glucuronide conjugates. Fecal metabolites were S-n-butyl S′-(1, 1-dimethyl-2-hydroxyethyl)benzyl N-3-pyridyldithiocarbonimidate [MR], A, B, C and D. These metabolites were also found in the bile. The pyridine-labeled S-1358 gave rise to 2-(3′-pyridylimino)-4-carboxylthiazolidine [HM] and 3-aminopyridine [AP] in the urine, and MR and AP in the feces. Intact S-1358 was a major component of the fecal radioactivity. 相似文献
132.
Seizo Sumida Yoshio Hisada Akiko Kometani Junshi Miyamoto 《Bioscience, biotechnology, and biochemistry》2013,77(9):2127-2136
Using 3-(3′,5′-dichlorophenyl)-5,5-dimethyloxazolidine-2,4-dione labeled with 14C or 3H, absorption, excretion, and tissue distribution in male Wistar rats were studied, and metabolites excreted were identified. At the dosage rates of 100, 300, 1000 and 3000 mg/kg, the maximum excretion of orally administered radioactivity occurred within 24 hr. Increase in the dosage rate was paralleled by decrease in the proportion of urinary elimination. Essentially all the radioactivity was excreted in 2 weeks. DDOD level was generally low in most tissues. Adipose tissue contained higher radioactivity compared with others. Most of the urinary metabolites identified were characterized by hydroxylation at the 4′ position of the benzene ring moiety, and hydrolytic or oxidative modification of the oxazolidine ring portion. 相似文献
133.
134.
Ayako Kitano Takeo Shimasaki Yuri Chikano Mitsutoshi Nakada Mayumi Hirose Tomomi Higashi Yasuhito Ishigaki Yoshio Endo Takahisa Takino Hiroshi Sato Yoshimichi Sai Ken-ichi Miyamoto Yoshiharu Motoo Kazuyuki Kawakami Toshinari Minamoto 《PloS one》2013,8(2)
Background and Purpose
The major obstacles to treatment of pancreatic cancer are the highly invasive capacity and resistance to chemo- and radiotherapy. Glycogen synthase kinase 3β (GSK3β) regulates multiple cellular pathways and is implicated in various diseases including cancer. Here we investigate a pathological role for GSK3β in the invasive and treatment resistant phenotype of pancreatic cancer.Methods
Pancreatic cancer cells were examined for GSK3β expression, phosphorylation and activity using Western blotting and in vitro kinase assay. The effects of GSK3β inhibition on cancer cell survival, proliferation, invasive ability and susceptibility to gemcitabine and radiation were examined following treatment with a pharmacological inhibitor or by RNA interference. Effects of GSK3β inhibition on cancer cell xenografts were also examined.Results
Pancreatic cancer cells showed higher expression and activity of GSK3β than non-neoplastic cells, which were associated with changes in its differential phosphorylation. Inhibition of GSK3β significantly reduced the proliferation and survival of cancer cells, sensitized them to gemcitabine and ionizing radiation, and attenuated their migration and invasion. These effects were associated with decreases in cyclin D1 expression and Rb phosphorylation. Inhibition of GSK3β also altered the subcellular localization of Rac1 and F-actin and the cellular microarchitecture, including lamellipodia. Coincident with these changes were the reduced secretion of matrix metalloproteinase-2 (MMP-2) and decreased phosphorylation of focal adhesion kinase (FAK). The effects of GSK3β inhibition on tumor invasion, susceptibility to gemcitabine, MMP-2 expression and FAK phosphorylation were observed in tumor xenografts.Conclusion
The targeting of GSK3β represents an effective strategy to overcome the dual challenges of invasiveness and treatment resistance in pancreatic cancer. 相似文献135.
Hiroyoshi Yamauchi Masashi Bando Tomohisa Baba Kensuke Kataoka Yoshihito Yamada Hiroshi Yamamoto Atsushi Miyamoto Soichiro Ikushima Takeshi Johkoh Fumikazu Sakai Yasuhiro Terasaki Akira Hebisawa Yoshinori Kawabata Yukihiko Sugiyama Takashi Ogura 《PloS one》2016,11(11)
Some patients with idiopathic pulmonary fibrosis (IPF) do not have honeycombing on high-resolution computed tomography (HRCT) at their initial evaluation. The clinical course and sequential changes in HRCT findings in these patients are not fully understood. We reviewed the cases of 43 patients with IPF without honeycombing on initial HRCT from institutions throughout Japan. All patients were diagnosed with IPF based on a surgical lung biopsy. Multidisciplinary discussions were held five times between 2011 and 2014, to exclude alternative etiologies. We evaluated the sequential changes in HRCT findings in 30 patients with IPF. We classified these 30 patients into three groups based on their HRCT patterns and clarified the clinical characteristics and prognosis among the groups. The patterns of all 30 patients on initial HRCT corresponded to a possible usual interstitial pneumonia (UIP) pattern which was described in the 2011 International Statement. On long-term follow-up (71.0±38.7 standard deviation [SD] months), honeycombing was seen in 16 patients (53%, the HoneyCo group); traction bronchiectasis or cysts without honeycombing was observed in 12 patients (40%, the NoHoneyCo group), and two patients showed no interval change (7%, the NoChange group) on HRCT. The mean survival periods of the HoneyCo and NoHoneyCo groups were 67.1 and 61.2 months, respectively (p = 0.76). There are some patients with IPF whose conditions chronically progress without honeycombing on HRCT. The appearance of honeycombing on HRCT during the follow-up might not be related to prognosis. 相似文献
136.
137.
Yuki Miyamoto Tomohiro Torii Kazuko Kawahara Akito Tanoue Junji Yamauchi 《Biochemistry and Biophysics Reports》2016
During embryonic development of the peripheral nervous system (PNS), Schwann cell precursors migrate along neuronal axons to their final destinations, where they will myelinate the axons after birth. While the intercellular signals controlling Schwann cell precursor migration are well studied, the intracellular signals controlling Schwann cell precursor migration remain elusive. Here, using a rat primary cell culture system, we show that Dock8, an atypical Dock180-related guanine-nucleotide exchange factor (GEF) for small GTPases of the Rho family, specifically interacts with Nck1, an adaptor protein composed only of Src homology (SH) domains, to promote Schwann cell precursor migration induced by platelet-derived growth factor (PDGF). Knockdown of Dock8 or Nck1 with its respective siRNA markedly decreases PDGF-induced cell migration, as well as Rho GTPase activation, in precursors. Dock8, through its unique N-terminal proline-rich motif, interacts with the SH3 domain of Nck1, but not with other adaptor proteins composed only of SH domains, e.g. Grb2 and CrkII, and not with the adaptor protein Elmo1. Reintroduction of the proline-rich motif mutant of Dock8 in Dock8 siRNA-transfected Schwann cell precursors fails to restore their migratory abilities, whereas that of wild-type Dock8 does restore these abilities. These results suggest that Nck1 interaction with Dock8 mediates PDGF-induced Schwann cell precursor migration, demonstrating not only that Nck1 and Dock8 are previously unanticipated intracellular signaling molecules involved in the regulation of Schwann cell precursor migration but also that Dock8 is among the genetically-conservative common interaction subset of Dock family proteins consisting only of SH domain adaptor proteins. 相似文献
138.
139.
Angiotensin II increases sperm phagocytosis by neutrophils in vitro: A possible physiological role in the bovine oviduct
下载免费PDF全文
![点击此处可从《Molecular reproduction and development》网站下载免费的PDF全文](/ch/ext_images/free.gif)
140.
Kazuhide Miyamoto Yukari Taguchi Kazuki Saito 《Protein science : a publication of the Protein Society》2019,28(2):448-453
Artificial RING fingers (ARFs) are created by transplanting active sites of RING fingers onto cross‐brace structures. Human hydroxymethylglutaryl‐coenzyme A reductase degradation protein 1 (HRD1) is involved in the degradation of the endoplasmic reticulum (ER) proteins. HRD1 possesses the RING finger domain (HRD1_RING) that functions as a ubiquitin‐ligating (E3) enzyme. Herein, we determined the solution structure of HRD1_RING using nuclear magnetic resonance (NMR). Moreover, using a metallochromic indicator, we determined the stoichiometry of zinc ions spectrophotometrically and found that HRD1_RING binds to two zinc atoms. The Simple Modular Architecture Research Tool database predicted the structure of HRD1_RING as a typical RING finger. However, it was found that the actual structure of HRD1_RING adopts an atypical RING‐H2 type RING fold. This structural analysis unveiled the position and range of the active site of HRD1_RING that contribute to its specific ubiquitin‐conjugating enzyme (E2)‐binding capability. 相似文献